-
European cannabis market set to be worth €115.7 billion by 2028
pharmafile
July 17, 2018
The European cannabis market is set to be worth €115.7 billion by 2028, according to a report released by the market intelligence firm Prohibition Partners.
-
The July/August issue of Pharmafocus is now live!
pharmafile
July 06, 2018
As cross- and inter-party squabbles ramp up and negotiations become ever more weighted with ominous importance, the day the UK will officially exit the European Union grows ever closer.
-
Global study by Novartis and European Migraine and Headache Alliance reveals 60% of employed people with severe migraine miss, on average, a week of work per month
worldpharmanews
July 05, 2018
Novartis and the European Migraine and Headache Alliance (EMHA) announced initial findings from the largest global migraine patient study to date, involving over 11,000 people from 31 countries.
-
AstraZeneca receives European clearance for lung cancer drug SHARE
pharmaceutical-technology
June 13, 2018
AstraZeneca has secured marketing clearance from the European Commission (EC) for its Tagrisso (osimertinib) drug to treat non-small cell lung cancer (NSCLC) in adults.
-
Changing of the guard at European chemical firms
newsnow
May 14, 2018
changing of the guard is under way in Europe as CEOs move on at the big chemical firms BASF, Borealis, Covestro, and Solvay.
-
Natoli Engineering Company Opens Facility in Poland
americanpharmaceuticalreview
March 17, 2017
Natoli is expanding their European presence by launching its newest business division, Natoli International, and with that, the opening of the Natoli Poland service and distribution facility, located in Poland.